Patent · US Active

Modified Cpn10 and PRR signalling

US9234019B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Assignee

CBIO LIMITED · AU

Inventors

Dean Jason Naylor · Forsayth, AU
Richard James Brown · Brisbane, AU
Christopher Bruce Howard · Calle de la Era, AU
Christopher John De Bakker · Margate, AU
Linda Alisson Ward · Brisbane, AU
Jeanette Elizabeth Stok · Brisbane, AU
Andrew Leigh James · Ipswich, AU
Daniel Scott Lambert · Bairnsdale, AU
Kylie Jane Ralston · Newcastle, AU
Walter Rene Antonius Van Heumen · Ipswich, AU

Key dates

Filing date	Apr 9, 2009
Grant date	Jan 12, 2016
Priority date	—
Expiry date	Oct 26, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to isolated Cpn10 polypeptides possessing an increased affinity for a PRR ligand compared to Ala Cpn10 polypeptide. In a further embodiment, the present invention also relates to modified chaperonin 10 polypeptides, and to nucleic acids encoding the same and to compositions comprising such polypeptides and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.